“AbbVie reported that sales from Ubrelvy and a similar migraine medication called Qulipta, generated $1.223billion in revenue for the company in 2023.”
No wonder Big Pharma funds Congress!
4 posted on 09/14/2024 7:40:03 AM PDT by goodnesswins
(DEI....Divide, Enslave, Indoctrinate.....OR ......Didn't Earn It)